Background A rise in the incidence of some autoimmune disorders has been described.
However, contemporary estimates of the overall incidence of autoimmune diseases and …

Introduction Around 18.7 million of the 537 million people with diabetes worldwide live in
low-income and middle-income countries (LMIC), where there is also an increase in the …

In children with type 1 diabetes, a healthy lifestyle is important to control postprandial
glycemia and to avoid hyperglycemic peaks that worsen the inflammatory state of vessels …

Background: During MiniMed™ advanced hybrid closed-loop (AHCL) use by adolescents
and adults in the pivotal trial, glycated hemoglobin (A1C) was significantly reduced, time …

Abstract Purpose of the Review Current global information on incidence, prevalence, and
mortality of type 1 diabetes (T1D) is limited, particularly in low-and middle-income countries …

Background To date, there is no data available depicting the trend of the incidence of type 1
and type 2 diabetes across all age groups for the COVID-19 pandemic years in Germany …

Type 1 diabetes (T1D) is one of the most common chronic diseases in childhood, with a
progressively increasing incidence. T1D management requires lifelong insulin treatment …

Abstract Background Type 1 diabetes (T1D) incidence in adolescents varies widely, but has
increased globally in recent years. This study reports T1D burden among adolescents and …

Type 1 diabetes mellitus (T1D) is an autoimmune disease caused by the destruction of
insulin-producing β-cells in the pancreas by cytotoxic T-cells. To date, there are no drugs …

The discovery and subsequent introduction of insulin therapy in 1922 led to fundamental
changes in the treatment and epidemiology of type 1 diabetes. In Boston, MA, USA, the life …